These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 9363828)

  • 21. Cortical spreading depression does not result in the release of calcitonin gene-related peptide into the external jugular vein of the cat: relevance to human migraine.
    Piper RD; Edvinsson L; Ekman R; Lambert GA
    Cephalalgia; 1993 Jun; 13(3):180-3; discussion 149. PubMed ID: 8395344
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pharmacological opportunities and pitfalls in the therapy of migraine.
    May A; Goadsby PJ
    Curr Opin Neurol; 2001 Jun; 14(3):341-5. PubMed ID: 11371757
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Faster, higher, further. Current thinking on acute and prophylactic treatment of migraine].
    Limmroth V; Hubrecht L; Diener HC
    Schmerz; 2004 Oct; 18(5):398-403. PubMed ID: 15322886
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pharmacological synergy: the next frontier on therapeutic advancement for migraine.
    Blumenfeld A; Gennings C; Cady R
    Headache; 2012 Apr; 52(4):636-47. PubMed ID: 22221151
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Effect of sumatriptan on cerebral blood flow during migraine headache: measurement by sequential SPECT used 99mTc-ECD background subtraction method].
    Ueda T; Torihara Y; Tsuneyoshi N; Ikeda Y
    No To Shinkei; 2001 Jul; 53(7):625-30. PubMed ID: 11517486
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Office Treatment of Migraine in 2004].
    Göbel H; Heinze A
    MMW Fortschr Med; 2004 May; 146 Spec No 2():31-2, 34, 36 passim. PubMed ID: 15376699
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Re: "Naratriptan in the prophylaxis of transformed migraine" (Sheftell FD Rapoport AM, Coddon DR. Headache.1999,39:506-510).
    Warner JS
    Headache; 2000 Mar; 40(3):252. PubMed ID: 10970177
    [No Abstract]   [Full Text] [Related]  

  • 28. Open-labeled long-term study of the efficacy, safety, and tolerability of subcutaneous sumatriptan in acute migraine treatment.
    Göbel H; Heinze A; Stolze H; Heinze-Kuhn K; Lindner V
    Cephalalgia; 1999 Sep; 19(7):676-83; discussion 626. PubMed ID: 10524662
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Neurogenic inflammation in the context of migraine.
    Williamson DJ; Hargreaves RJ
    Microsc Res Tech; 2001 May; 53(3):167-78. PubMed ID: 11301492
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Serotonin receptor targeted therapy for migraine treatment: an overview of drugs in phase I and II clinical development.
    Barbanti P; Aurilia C; Egeo G; Fofi L; Palmirotta R
    Expert Opin Investig Drugs; 2017 Mar; 26(3):269-277. PubMed ID: 28103158
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prolonged migraine aura without headache arrested by sumatriptan. A case report with further considerations.
    Kowacs PA; Piovesan EJ; Tatsui CE; Lange MC; Ribas LC; Werneck LC
    Cephalalgia; 1999 May; 19(4):241-2. PubMed ID: 10376169
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Hypothalamic activation in spontaneous migraine attacks.
    Denuelle M; Fabre N; Payoux P; Chollet F; Geraud G
    Headache; 2007; 47(10):1418-26. PubMed ID: 18052951
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The pathophysiological and pharmacological basis of current drug treatment of migraine headache.
    Reddy DS
    Expert Rev Clin Pharmacol; 2013 May; 6(3):271-88. PubMed ID: 23656340
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Selective inhibition of 5-HT7 receptor reduces CGRP release in an experimental model for migraine.
    Wang X; Fang Y; Liang J; Yin Z; Miao J; Luo N
    Headache; 2010 Apr; 50(4):579-87. PubMed ID: 20236348
    [TBL] [Abstract][Full Text] [Related]  

  • 35. 5HT1F- and 5HT7-receptor agonists for the treatment of migraines.
    Agosti RM
    CNS Neurol Disord Drug Targets; 2007 Aug; 6(4):235-7. PubMed ID: 17691977
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Migraine and cluster headache--their management with sumatriptan: a critical review of the current clinical experience.
    Wilkinson M; Pfaffenrath V; Schoenen J; Diener HC; Steiner TJ
    Cephalalgia; 1995 Oct; 15(5):337-57. PubMed ID: 8536293
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Migraine: sumatriptan].
    Yamada K; Naritomi H
    Nihon Naika Gakkai Zasshi; 2001 Apr; 90(4):607-12. PubMed ID: 11391907
    [No Abstract]   [Full Text] [Related]  

  • 38. Treatment of acute migraine attacks.
    Weintraub JR
    J Am Osteopath Assoc; 2000 Sep; 100(9 Suppl):S1-7. PubMed ID: 11070658
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Triptans: over the migraine.
    Cologno D; Mazzeo A; Lecce B; Mundi C; Petretta V; Casucci G; d'Onofrio F
    Neurol Sci; 2012 May; 33 Suppl 1():S193-8. PubMed ID: 22644202
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Tolerability of sumatriptan: clinical trials and postmarketing experience.
    Allen C; Dayno J
    Cephalalgia; 2001 Oct; 21(8):855-6. PubMed ID: 11737014
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.